Company Description

PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expert-based contract research, consulting, medical communications, and technology solutions to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the devel... More >>

Q1 2017 Quarterly ResultsMore Info >>
Earnings Press Release
Q1 Financial Results and Trended Information

Recent NewsMore Info >>
PAREXEL International Reports First Quarter Fiscal Year 2017 Results and Announces New Share Repurchase Program
PAREXEL International to Present at Credit Suisse Healthcare Conference
PAREXEL International Announces Date of First Quarter Fiscal Year 2017 Earnings Release and Conference Call

EventsMore Info >>
PAREXEL International Investor Day 2016
Thursday, June 30, 2016 9:00 a.m. ET
Supporting Materials
Download Event Supporting Material PAREXEL’s 2016 Investor Day Presentation

Q1 2017 PAREXEL International Earnings Conference Call
Thursday, October 27, 2016 10:00 a.m. ET

PAREXEL International at Credit Suisse Healthcare Conference
Monday, November 7, 2016 10:00 a.m. MT
remind me days before the event

Enter your e-mail address